Advancing Precision Oncology Through Clinical Research & Partnerships
GenTraceDx is being developed as a next-generation precision oncology platform that integrates multiomic sequencing with continuously updating clinical intelligence.
Built in collaboration with leading clinical and genomic institutions, the platform is designed to support real-world oncology care while enabling large-scale clinical research and data-driven discovery.
A Platform Built for Clinical and Translational Research
GenTraceDx combines tumour–normal whole exome sequencing (WES), whole transcriptome RNA sequencing, and a longitudinal reanalysis engine to generate continuously evolving clinical insights.
This approach enables:
- Longitudinal analysis of patient-specific genomic profiles
- Integration of emerging therapies, biomarkers, and clinical evidence
- Real-world insights into treatment response, resistance, and disease progression
GenTraceDx is designed to connect clinical care with scalable, data-driven research.
Multiomic Data and Longitudinal Clinical Intelligence
The platform is being developed to generate structured, high-quality data across:
- Somatic and germline genomic variants (WES)
- Gene expression and transcriptomic profiling (RNA-seq)
- Structural variants and copy number alterations
- Longitudinal clinical context and treatment history
This data is continuously reanalyzed as new evidence emerges, enabling:
- Dynamic interpretation over time
- Identification of new therapeutic opportunities
- Generation of real-world clinical evidence
This creates a continuously evolving clinical intelligence layer across patients and populations.
Developed in Partnership with Leading Institutions
GenTraceDx is being developed through a collaboration between:
Industry Lead
Research Lead
and is supported through funding from:
Funding Partner
Funding Partner
This model enables:
- Clinical-grade sequencing and analysis
- Integration into real-world oncology workflows
- Alignment with national research and innovation priorities
Opportunities for Clinical Research and Collaboration
GenTraceDx is designed to support collaboration with:
- Academic research groups
- Clinical investigators and oncology centers
- Computational biology and AI teams
- Biopharma and industry partners in oncology and therapeutics
Areas of collaboration may include:
- Biomarker discovery and validation
- Longitudinal genomic and transcriptomic analysis
- Real-world evidence generation
- Development of AI-driven clinical interpretation models
Data Governance and Responsible Access
Access to data and collaboration opportunities will be structured in alignment with:
- Institutional partnerships
- Ethical and regulatory frameworks
- Patient privacy and data governance standards
GenTraceDx is being developed with a strong emphasis on responsible data use and clinical integrity.
Explore Partnership Opportunities
If you are interested in collaborating with GenTraceDx, we invite you to connect with our team.
Partner with GenTraceDx
We collaborate with academic institutions, clinical investigators, and biopharma partners to advance precision oncology. Complete the form below to connect with our team.